Published in Mol Biochem Parasitol on February 01, 1987
In vitro activity of riboflavin against the human malaria parasite Plasmodium falciparum. Antimicrob Agents Chemother (2000) 0.89
Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science (2000) 7.41
CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes. Cell (1989) 3.56
Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds. J Biol Chem (1998) 2.72
Electric excitability of the cerebrum (Uber die elektrische Erregbarkeit des Grosshirns). Epilepsy Behav (2009) 2.71
Substrate positions and induced-fit in crystalline adenylate kinase. J Mol Biol (1977) 2.69
Enzyme inactivation through sulfhydryl oxidation by physiologic NO-carriers. Nat Struct Biol (1998) 2.35
Conservation, localization and expression of HopZ, a protein involved in adhesion of Helicobacter pylori. Nucleic Acids Res (1999) 1.97
Comparison of vascular smooth muscle cells from adult human, monkey and rabbit in primary culture and in subculture. Cell Tissue Res (1977) 1.92
The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro. Blood (1999) 1.87
Localization of myosin, actin, and tropomyosin in rat intestinal epithelium: immunohistochemical studies at the light and electron microscope levels. J Cell Biol (1980) 1.79
Inhibition of cell aggregation by antibodies directed against actomyosin. Nature (1970) 1.78
Aggregative behaviour of embryonic chick cells in the presence of antibodies directed against actomyosins. J Cell Sci (1971) 1.77
Thioredoxin reductase two modes of catalysis have evolved. Eur J Biochem (2000) 1.70
The thioredoxin system of the malaria parasite Plasmodium falciparum. Glutathione reduction revisited. J Biol Chem (2000) 1.63
Thioredoxin reductase as a pathophysiological factor and drug target. Eur J Biochem (2000) 1.63
Glutathione reductase from human erythrocytes. The sequences of the NADPH domain and of the interface domain. Eur J Biochem (1982) 1.63
Absence of myosin-like immunoreactivity in stereocilia of cochlear hair cells. Nature (1982) 1.62
The structure of the flavoenzyme glutathione reductase. Nature (1978) 1.61
Ultrastructural evidence for myosin of the smooth muscle type at the surface of trypsin-dissociated embryonic chick cells. J Cell Sci (1974) 1.57
The mechanism of thioredoxin reductase from human placenta is similar to the mechanisms of lipoamide dehydrogenase and glutathione reductase and is distinct from the mechanism of thioredoxin reductase from Escherichia coli. Proc Natl Acad Sci U S A (1997) 1.56
Synthetic inhibitors of adenylate kinases in the assays for ATPases and phosphokinases. Eur J Biochem (1975) 1.55
Comparative studies of human smooth and striated muscle myosins. Biochim Biophys Acta (1971) 1.54
Lack of DNA synthesis among CD34+ cells in cord blood and in cytokine-mobilized blood. Br J Haematol (1996) 1.48
The color purple: from royalty to laboratory, with apologies to Malachowski. Biotech Histochem (2011) 1.48
Topological comparison of adenyl kinase with other proteins. Nature (1974) 1.45
Molecular cloning, genomic structure and localization in a blood stage antigen of Plasmodium falciparum characterized by a serine stretch. Mol Biochem Parasitol (1989) 1.42
Three-dimensional structure of glutathione reductase at 2 A resolution. J Mol Biol (1981) 1.32
Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation. Leukemia (2010) 1.25
Condensation of the chromatin at the membrane of an apoptotic nucleus is not associated with activation of an endonuclease. J Cell Sci (1993) 1.25
Vascular smooth muscle caldesmon. J Biol Chem (1986) 1.24
Production of specific antibodies to contractile proteins, and their use in immunofluorescence microscopy. II. Species-specific and species-non-specific antibodies to smooth and striated chicken muscle actin. Histochemistry (1977) 1.23
A hypothesis on the catalytic mechanism of the selenoenzyme thioredoxin reductase. Biochem J (1998) 1.23
The thioredoxin system of Plasmodium falciparum and other parasites. Cell Mol Life Sci (2002) 1.22
Trypanothione reductase from Trypanosoma cruzi. Purification and characterization of the crystalline enzyme. Eur J Biochem (1987) 1.21
Structural relationships in the adenylate kinase family. Eur J Biochem (1986) 1.18
[The particularities of contractile proteins of the arteries]. Biochem Z (1965) 1.18
FAD-binding site of glutathione reductase. J Mol Biol (1982) 1.18
Production of specific antibodies to contractile proteins, and their use in immunofluorescence microscopy. I. Antibodies to smooth and striated chicken muscle myosins. Histochemistry (1976) 1.16
Folding of the four domains and dimerization are impaired by the Gly446-->Glu exchange in human glutathione reductase. Implications for the design of antiparasitic drugs. Biochemistry (1993) 1.13
FITC-labelled antibody staining of tropomyosin-containing fibrils in smooth, cardiac and skeletal muscle cells, prefusion myoblasts, fibroblasts, endothelial cells and 3T3 cells in culture. Cell Tissue Res (1977) 1.12
A histidin alanine rich recombinant antigen protects Aotus monkeys from P. falciparum infection. Behring Inst Mitt (1988) 1.12
Safety and immunogenicity of an intranasal Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers. Vaccine (2001) 1.12
The enzymatic synthesis of thiophosphate analogs of nucleotides. Biochim Biophys Acta (1972) 1.11
Expression of the target receptor CD33 in CD34+/CD38-/CD123+ AML stem cells. Eur J Clin Invest (2007) 1.11
Flow cytometric assessment of human MIC2 expression in bone marrow, thymus, and peripheral blood. Blood (1994) 1.10
Plasmodium falciparum aldolase: gene structure and localization. Mol Biochem Parasitol (1990) 1.08
Changes in myosin distribution in dedifferentiating and redifferentiating smooth muscle cells in tissue culture. Cell Tissue Res (1975) 1.08
Abolition by myosin and heavy meromyosin of the inhibitory effect of smooth-muscle actomyosin antibodies on cell aggregation in vitro. J Cell Sci (1973) 1.08
Fluorescent and spin label probes of the environments of the sulfhydryl groups of porcine muscle adenylate kinase. J Biol Chem (1975) 1.07
Recombinant Plasmodium falciparum glutathione reductase is inhibited by the antimalarial dye methylene blue. FEBS Lett (1998) 1.07
Plasmodium vinckei: suppression of mouse infections with desferrioxamine B. Exp Parasitol (1985) 1.05
Glutathione reductase of the malarial parasite Plasmodium falciparum: crystal structure and inhibitor development. J Mol Biol (2003) 1.05
Characterisation of synthetic beta-haematin and effects of the antimalarial drugs quinidine, halofantrine, desbutylhalofantrine and mefloquine on its formation. J Inorg Biochem (1999) 1.04
Safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers. Infect Immun (1999) 1.03
Antibody to thymus myosin: its immunological characterization and use for immunocytochemical localization of myosin in vertebrate nonmuscle cells. Eur J Cell Biol (1983) 1.03
Microcompartmentation of glycolytic enzymes in cultured cells. Eur J Cell Biol (1992) 1.02
Surface expression of malarial antigens in Salmonella typhimurium: induction of serum antibody response upon oral vaccination of mice. Vaccine (1991) 1.02
Protection of Aotus monkeys from malaria infection by immunization with recombinant hybrid proteins. Infect Immun (1992) 1.02
Distinction between smooth muscle, fibroblasts and endothelial cells in culture by the use of fluoresceinated antibodies against smooth muscle actin. Cell Tissue Res (1977) 1.02
Monocyte enrichment from leukapharesis products for the generation of DCs by plastic adherence, or by positive or negative selection. Cytotherapy (2003) 1.01
A new blood stage antigen of Plasmodium falciparum highly homologous to the serine-stretch protein SERP. Mol Biochem Parasitol (1991) 1.00
Pre-emptive treatment of CMV DNAemia in paediatric stem cell transplantation: the impact of recipient and donor CMV serostatus on the incidence of CMV disease and CMV-related mortality. Bone Marrow Transplant (2003) 1.00
Antibody staining of 10-nm (100-A) filaments in cultured smooth, cardiac and skeletal muscle cells. J Cell Sci (1979) 0.99
Glutathione reductase and glutamate dehydrogenase of Plasmodium falciparum, the causative agent of tropical malaria. Eur J Biochem (1996) 0.99
Properties and distribution of the protein inhibitor (Mr 17,000) of protein kinase C. Biochem J (1987) 0.99
A new blood stage antigen of Plasmodium falciparum transported to the erythrocyte surface. Mol Biochem Parasitol (1989) 0.99
Cloning and sequencing of mammalian glutathione reductase cDNA. Eur J Biochem (1990) 0.98
CT diagnosis of thrombosis of dural sinuses in childhood. Eur J Radiol (1984) 0.98
Horner's syndrome after treatment of tension pneumothorax with tube thoracostomy in a newborn infant. Eur J Pediatr (1980) 0.97
Redox processes in malaria and other parasitic diseases. Determination of intracellular glutathione. Histochemistry (1994) 0.97
Glutathione reductase from human erythrocytes: amino-acid sequence of the structurally known FAD-binding domain. Eur J Biochem (1981) 0.97
Induction of apoptosis in cultured hepatocytes and in the regressing liver by transforming growth factor-beta 1 occurs without activation of an endonuclease. Toxicol Lett (1992) 0.97
MR imaging of the central nervous system in diving-related decompression illness. Acta Radiol (1997) 0.96
Trypanothione reductase from Trypanosoma cruzi. Catalytic properties of the enzyme and inhibition studies with trypanocidal compounds. Eur J Biochem (1989) 0.96
In vitro biosynthesis and membrane translocation of the serine rich protein of Plasmodium falciparum. Mol Biochem Parasitol (1990) 0.95
Fatty acid binding of myoglobin depends on its oxygenation. Biol Chem Hoppe Seyler (1994) 0.94
Glutathione reductase-deficient erythrocytes as host cells of malarial parasites. Biochem Pharmacol (1988) 0.94
Deletion of the parasite-specific insertions and mutation of the catalytic triad in glutathione reductase from chloroquine-sensitive Plasmodium falciparum 3D7. Mol Biochem Parasitol (2000) 0.94
A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline. J Med Chem (2001) 0.94
Myeloperoxidase expression in CD34+ normal human hematopoietic cells. Blood (1993) 0.94
Ontogenetic scaling of foot musculoskeletal anatomy in elephants. J R Soc Interface (2008) 0.94
Glutathione reductase inhibitors as potential antimalarial drugs. Effects of nitrosoureas on Plasmodium falciparum in vitro. Biochem Pharmacol (1988) 0.94
Demonstration of alternative splicing of a pre-mRNA expressed in the blood stage form of Plasmodium falciparum. J Biol Chem (1991) 0.94
Effectiveness of non-cardiac preoperative testing in non-cardiac elective surgery: a systematic review. Br J Anaesth (2013) 0.93
Immunohistochemical localization and molecular characteristics of three monoclonal antibody-defined epitopes detectable on carcinoembryonic antigen (CEA). Int J Cancer (1985) 0.93
Transplantation of highly purified peripheral blood CD34+ cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment. Leukemia (1999) 0.93
Origin of human mast cells: development from transplanted hematopoietic stem cells after allogeneic bone marrow transplantation. Blood (1994) 0.93
Responses of T cells from sensitized donors to recombinant and synthetic peptides corresponding to sequences of the Plasmodium falciparum SERP antigen. Immunol Lett (1990) 0.93
Early recipient chimerism testing in the T- and NK-cell lineages for risk assessment of graft rejection in pediatric patients undergoing allogeneic stem cell transplantation. Leukemia (2011) 0.92
Myosin autoantibodies detected by immunofluorescence. Clin Exp Immunol (1977) 0.92
Glutathione reductase from human erythrocytes. Isolation of the enzyme and sequence analysis of the redox-active peptide. Eur J Biochem (1977) 0.92
Diphtheria booster vaccination: one or two injections? Vaccine (1999) 0.91
The bacterial redox signaller pyocyanin as an antiplasmodial agent: comparisons with its thioanalog methylene blue. Redox Rep (2011) 0.91
Myosin and actin containing cells in the human postnatal thymus. Ultrastructural and immunohistochemical findings in normal thymus and in myasthenia gravis. Virchows Arch B Cell Pathol Incl Mol Pathol (1979) 0.91
Immunochemistry of cytoplasmic contractile proteins. Int Rev Cytol (1980) 0.91
Immunoprecipitation of a cytoplasmic precursor of rat-liver cytochrome oxidase. Eur J Biochem (1978) 0.90
Immunofluorescence-microscopic demonstration of myosin and actin in salivary glands and exocrine pancreas of the rat. Cell Tissue Res (1977) 0.90